| Obesity |
1 |
1 |
| Cancer |
0 |
0.98 |
| Cancer Risk |
0 |
0.99 |
| Breast Cancer |
0 |
0.7 |
| Noncolorectal Gastrointestinal Cancer |
0 |
0.67 |
| Pancreatic Cancer |
0 |
0.65 |
| Lung Cancer |
0 |
0.63 |
| Prostate Cancer |
0 |
0.63 |
| Biologic Therapy |
0 |
0.61 |
| Genomic Medicine |
0 |
0.59 |
| Gallbladder Cancer |
0 |
0.56 |
| COVID-19 |
0 |
0.5 |
| Breast |
0 |
0.15 |
| Esophageal Adenocarcinoma |
0 |
0.11 |
| Genetics |
0 |
0.11 |
| Prostate |
0 |
0.1 |
| Lung |
0 |
0.08 |
| Prostate Specific Antigen |
0 |
0.08 |
| Adenocarcinoma |
0 |
0.06 |
| Body Mass Index |
0 |
0.06 |
| Esophagus |
0 |
0.06 |
| Multiple Myeloma |
0 |
0.06 |
| Adolescent Medicine |
0 |
0.04 |
| Child |
0 |
0.04 |
| Kidney |
0 |
0.04 |
| Hypertension |
0 |
0.03 |
| Antigens |
0 |
0.02 |
| Biliary Tract |
0 |
0.02 |
| Cardiovascular disease |
0 |
0.02 |
| Cardiovascular Risk Management |
0 |
0.02 |
| Estrogen |
0 |
0.02 |
| Gallbladder |
0 |
0.02 |
| Meta-Analysis |
0 |
0.02 |
| Ovary |
0 |
0.02 |
| Pancreas |
0 |
0.02 |
| Rectum |
0 |
0.02 |
| Tissue |
0 |
0.02 |
| Washington |
0 |
0.02 |
| Weight Gain |
0 |
0.02 |
| Weight Management |
0 |
0.02 |